Tender

Quantity Surveyor/Contract Administrator/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre

MEDICINES DISCOVERY CATAPULT

This public procurement record has 1 release in its history.

Tender

09 Apr 2021 at 07:53

Summary of the contracting process

The Medicines Discovery Catapult (MDC) is currently in the tender stage for a procurement process titled "Quantity Surveyor/Contract Administrator/BSL3 Laboratory – Full and complete service for the duration of the project life cycle Validation Centre," classified under the construction work industry. The tender, with a value of £55,000, is based in Cheshire and aims to develop a national facility for testing and validation of new diagnostics and therapeutics to address urgent health needs. The submission deadline is 30 April 2021, and the contract period will last for 360 days from the award date, which follows the opening of bids on the same day.

This tender presents significant opportunities for businesses specialising in construction and engineering services, particularly those with expertise in healthcare infrastructure. Companies looking to enhance their market presence should consider submitting proposals if they have the relevant skills in quantity surveying or contract administration, as this project aims to foster growth in high-value jobs and innovative diagnostics within the UK's healthcare sector. Collaborating with MDC, an independent not-for-profit focused on R&D, will also provide invaluable networking opportunities in a rapidly evolving industry.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Quantity Surveyor/Contract Administrator/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre

Notice Description

Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545

Lot Information

Lot 1

Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02a415
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/007332-2021
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Works
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

45 - Construction work

71 - Architectural, construction, engineering and inspection services


CPV Codes

45000000 - Construction work

71000000 - Architectural, construction, engineering and inspection services

Notice Value(s)

Tender Value
£55,000 Under £100K
Lots Value
£55,000 Under £100K
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
9 Apr 20214 years ago
Submission Deadline
30 Apr 2021Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
MEDICINES DISCOVERY CATAPULT
Contact Name
Mr Kieran McGowan
Contact Email
kieran.mcgowan@md.catapult.org.uk
Contact Phone
+44 1625708394

Buyer Location

Locality
CHESHIRE
Postcode
SK10 4TG
Post Town
Stockport
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD6 Cheshire
Small Region (ITL 3)
TLD62 Cheshire East
Delivery Location
TLD62 Cheshire East

Local Authority
Cheshire East
Electoral Ward
Chelford
Westminster Constituency
Tatton

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02a415-2021-04-09T08:53:55+01:00",
    "date": "2021-04-09T08:53:55+01:00",
    "ocid": "ocds-h6vhtk-02a415",
    "initiationType": "tender",
    "tender": {
        "id": "DN537124",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Quantity Surveyor/Contract Administrator/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "45000000",
            "description": "Construction work"
        },
        "mainProcurementCategory": "works",
        "description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545",
        "value": {
            "amount": 55000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545",
                "value": {
                    "amount": 55000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "durationInDays": 360
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "status": "active"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "71000000",
                        "description": "Architectural, construction, engineering and inspection services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKD62"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545",
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2021-04-30T12:00:00+01:00"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "awardPeriod": {
            "startDate": "2021-04-30T12:05:00+01:00"
        },
        "bidOpening": {
            "date": "2021-04-30T12:05:00+01:00"
        },
        "hasRecurrence": false
    },
    "parties": [
        {
            "id": "GB-FTS-1022",
            "name": "Medicines Discovery Catapult",
            "identifier": {
                "legalName": "Medicines Discovery Catapult"
            },
            "address": {
                "streetAddress": "Block 35, Mereside, Alderley Park",
                "locality": "Cheshire",
                "region": "UKD62",
                "postalCode": "SK10 4TG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mr Kieran McGowan",
                "telephone": "+44 1625708394",
                "email": "Kieran.McGowan@md.catapult.org.uk",
                "url": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://md.catapult.org.uk/",
                "buyerProfile": "https://md.catapult.org.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "description": "Research - Drug Discovery / Health"
                    },
                    {
                        "scheme": "COFOG",
                        "description": "Research - Drug Discovery / Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-10403",
            "name": "Medicines Discovery Catapult",
            "identifier": {
                "legalName": "Medicines Discovery Catapult"
            },
            "address": {
                "streetAddress": "Block 35, Mereside, Alderley Park",
                "locality": "Macclesfield",
                "postalCode": "SK10 4TG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "kieran.mcgowan@md.catapult.org.uk"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-1022",
        "name": "Medicines Discovery Catapult"
    },
    "language": "en"
}